JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Outcomes and validity of risk stratification tools for endoscopic submucosal dissection of early gastric cancer in Western Australia

  • 0Department of Gastroenterology Royal Perth Hospital Perth Western Australia Australia.
Jgh Open : an Open Access Journal of Gastroenterology and Hepatology +

|

November 18, 2024

|

November 18, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Endoscopic submucosal dissection (ESD) is effective for gastric neoplasia in Western patients. This study shows excellent outcomes and supports eCura for post-procedure management.

Area Of Science

  • Gastroenterology
  • Endoscopic Surgery
  • Oncology

Background

  • Endoscopic submucosal dissection (ESD) is a primary treatment for superficial gastric neoplasms.
  • Western data on ESD risk stratification tools are limited.
  • This study evaluates ESD outcomes and risk stratification in a Western cohort.

Purpose Of The Study

  • To evaluate clinical outcomes of ESD for gastric neoplasia in a Western cohort.
  • To explore risk stratification tools for ESD.
  • To compare outcomes with published Western series.

Main Methods

  • Retrospective, observational cohort study.
  • 112 patients over 13 years at a tertiary referral center.
  • Primary outcomes: en bloc, complete (R0), and curative resection rates.

Main Results

  • High rates of en bloc (96.4%), R0 (89.3%), and curative resection (78.6%).
  • Low adverse events (5.8%), no recurrence, and 9.9% metachronous lesions.
  • Outcomes favorably compared with existing Western series, showing increasing ESD adoption.

Conclusions

  • ESD is a safe and effective treatment for gastric neoplasia in the West.
  • Excellent outcomes are achievable in diverse patient groups.
  • The eCura system is supported for guiding post-procedural management.

Keywords: